Literature DB >> 2356703

Visual impairment of age-related macular degeneration. An epidemiological study of 1000 aged individuals.

T Vinding1.   

Abstract

To emphasize the unknown visual impairment of age-related macular degeneration (AMD)-defined as macular changes causing a visual acuity of 6/9 or less-an epidemiological study was designed including 1000 age stratified and randomly selected Danes, 60-80 years of age. Among the 924 individuals in whom both maculae could be examined (1848 eyes) a total number of 173 AMD eyes was found in 112 persons. For all AMD eyes, the composition of visual loss can be described as an iceberg with minor visual impairment of 6/9-6/12 as the predominant base (71.7%), partial impairment of 6/18-6/36 as an interjacent area (15.0%) and major impairment of 6/60 or less (i.e. blindness) as the top (13.3%). By use of a logistric regression model the proportion of exudative macular degeneration among all AMD eyes (atrophic + exudative) was demonstrated to be significantly increasing with decreasing visual acuity but unrelated to age. The prevalence rates of AMD were age related in each of the visual subgroups of minor, partial and major impaired eyes. The prevalence rates of social blindness (6/60 or less in both eyes) due to AMD are estimated to be 4.3 per 1000 persons and of monocular blindness 16.2 per 1000. Further calculations suggest that about 90,000 out of 870,000 Danes. 60-80 years old, have visual impairment of 6/9 or less caused by AMD in one or both eyes.

Entities:  

Mesh:

Year:  1990        PMID: 2356703     DOI: 10.1111/j.1755-3768.1990.tb01898.x

Source DB:  PubMed          Journal:  Acta Ophthalmol (Copenh)        ISSN: 0001-639X


  13 in total

1.  Dissection of genomewide-scan data in extended families reveals a major locus and oligogenic susceptibility for age-related macular degeneration.

Authors:  Sudha K Iyengar; Danhong Song; Barbara E K Klein; Ronald Klein; James H Schick; Jennifer Humphrey; Christopher Millard; Rachel Liptak; Karlie Russo; Gyungah Jun; Kristine E Lee; Bonnie Fijal; Robert C Elston
Journal:  Am J Hum Genet       Date:  2003-12-19       Impact factor: 11.025

2.  Macular degeneration: how big is the problem?

Authors:  E Cheraskin
Journal:  J Natl Med Assoc       Date:  1992-10       Impact factor: 1.798

Review 3.  LOC387715/HTRA1 gene polymorphisms and susceptibility to age-related macular degeneration: A HuGE review and meta-analysis.

Authors:  Yu Tong; Jing Liao; Yuan Zhang; Jing Zhou; Hengyu Zhang; Meng Mao
Journal:  Mol Vis       Date:  2010-10-05       Impact factor: 2.367

4.  Clinicopathological correlation of deep retinal vascular anomalous complex in age related macular degeneration.

Authors:  B A Lafaut; S Aisenbrey; C Vanden Broecke; K U Bartz-Schmidt
Journal:  Br J Ophthalmol       Date:  2000-11       Impact factor: 4.638

Review 5.  Age-related macular degeneration: epidemiology and optimal treatment.

Authors:  Morten la Cour; Jens Folke Kiilgaard; Mogens Holst Nissen
Journal:  Drugs Aging       Date:  2002       Impact factor: 3.923

6.  Prevalence and the risk factors for visual impairment in age-related macular degeneration.

Authors:  S Srinivasan; G Swaminathan; V Kulothungan; R Raman; T Sharma
Journal:  Eye (Lond)       Date:  2017-05-26       Impact factor: 3.775

Review 7.  How big is the burden of visual loss caused by age related macular degeneration in the United Kingdom?

Authors:  C G Owen; A E Fletcher; M Donoghue; A R Rudnicka
Journal:  Br J Ophthalmol       Date:  2003-03       Impact factor: 4.638

8.  Measuring visual function in age-related macular degeneration with frequency-doubling (matrix) perimetry.

Authors:  Andrew John Anderson; Chris A Johnson; John S Werner
Journal:  Optom Vis Sci       Date:  2011-07       Impact factor: 1.973

9.  Visual impairment and blindness in Europe and their prevention.

Authors:  I Kocur; S Resnikoff
Journal:  Br J Ophthalmol       Date:  2002-07       Impact factor: 4.638

10.  Is asthma related to choroidal neovascularization?

Authors:  Yaoyao Sun; Wenzhen Yu; Lvzhen Huang; Jing Hou; Peihua Gong; Yi Zheng; Mingwei Zhao; Peng Zhou; Xiaoxin Li
Journal:  PLoS One       Date:  2012-05-02       Impact factor: 3.240

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.